Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-23
2007-10-23
Ungar, Susan (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C530S388800, C530S391100
Reexamination Certificate
active
10053758
ABSTRACT:
The present invention is directed to monoclonal or recombinant antibodies or fragments thereof that bind to human telomerase reverse transcriptase (hTRT) protein. The present invention is also directed to methods of identifying or detecting hTRT polypeptides in biological samples. The invention is further directed to methods of generating antibodies that specifically bind to hTRT protein.
REFERENCES:
patent: 3817837 (1974-06-01), Tanenholtz et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5001225 (1991-03-01), Taylor
patent: 5489508 (1996-02-01), West et al.
patent: 5583016 (1996-12-01), Villeponteau et al.
patent: 5597697 (1997-01-01), Diamond
patent: 5747317 (1998-05-01), Cao
patent: 5770422 (1998-06-01), Collins
patent: 5917025 (1999-06-01), Collins
patent: 5919656 (1999-07-01), Harrington et al.
patent: 6093809 (2000-07-01), Cech et al.
patent: 6166178 (2000-12-01), Cech et al.
patent: 6258535 (2001-07-01), Villeponteau et al.
patent: 6261556 (2001-07-01), Weinrich et al.
patent: 6261836 (2001-07-01), Cech et al.
patent: 6309867 (2001-10-01), Cech et al.
patent: 6337200 (2002-01-01), Morin
patent: 6440735 (2002-08-01), Gaeta
patent: 6444650 (2002-09-01), Cech et al.
patent: 6475789 (2002-11-01), Cech et al.
patent: 6517834 (2003-02-01), Weinrich et al.
patent: 6608188 (2003-08-01), Tsuchiya et al.
patent: 6610839 (2003-08-01), Morin et al.
patent: 6617110 (2003-09-01), Cech et al.
patent: 6627619 (2003-09-01), Cech et al.
patent: 2002/0164786 (2002-11-01), Cech et al.
patent: 2002/0187471 (2002-12-01), Cech et al.
patent: 2003/0009019 (2003-01-01), Cech et al.
patent: 2003/0044953 (2003-03-01), Cech et al.
patent: 2003/0059787 (2003-03-01), Cech et al.
patent: 2003/0096344 (2003-05-01), Cech et al.
patent: 2003/0100093 (2003-05-01), Cech et al.
patent: 2271718 (1998-05-01), None
patent: 2 317 891 (1998-04-01), None
patent: 82/01461 (1982-05-01), None
patent: WO 84/03564 (1984-09-01), None
patent: WO 93/23572 (1993-11-01), None
patent: WO 94/17210 (1994-08-01), None
patent: WO 95/13382 (1995-05-01), None
patent: WO 96/01835 (1996-01-01), None
patent: WO 96/12811 (1996-05-01), None
patent: WO 96/19580 (1996-06-01), None
patent: WO 96/40868 (1996-12-01), None
patent: 09154575 (1997-06-01), None
patent: WO 98/01542 (1998-01-01), None
patent: WO 98/01543 (1998-01-01), None
patent: WO 98/08938 (1998-02-01), None
patent: WO 98/07838 (1998-03-01), None
patent: WO 98/14592 (1998-04-01), None
patent: WO 98/14593 (1998-04-01), None
patent: WO 98/21343 (1998-05-01), None
patent: WO 98/23759 (1998-06-01), None
patent: WO 98/37181 (1998-08-01), None
patent: WO 98/45450 (1998-10-01), None
patent: WO98/59040 (1998-12-01), None
patent: WO99/01560 (1999-01-01), None
patent: WO 99/33998 (1999-07-01), None
patent: WO 99/38964 (1999-08-01), None
patent: WO 00/46355 (2000-08-01), None
Johnstone and THorpe (Immunochemistry in Practice, 2nd Ed., Blackwell Scientific Publications, Oxford, pp. 30, 49-50).
Huston et al (PNAS, 1988, 85:5879-5883).
Yi et al (Nucleic acids Research, 2001, 23:4818I-4825).
Krams et al (Am. J. Pathol., 2001, 159:1925-1932).
Ohyashiki et al (Brit. J. Can., 2005, 92:1942-2947).
Hirashima (Int. Arch. Allergy Immunol., 2000, Suppl 1:6-9).
Benedict et al (J. Exp. Medicine, 2001, 193(1):89-99).
Jiang et al (JBC, 2003, 278(7) 4763-4769.
Nair et al., J. Immunol 2000 165(12): 6949-6955.
Roitt et al (Immunology, 1993, Mosby, St. Louis, p. 6.4-6.5).
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al ( J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
1994 Genome Issue ofScience(265:1981f).
Anderson and Young, “Quantitative Filter Hybridization” inNucleic Acid Hybridizationpp. 73-111 (1985).
Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons, New York NY (1989).
Autexier et al., “Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA,” (1996)EMBO J,15:5928.
Autexier, C. et al, “Telomerase and cancer: revisiting the telomere hypothesis,” Trends in Biochemical Sciences, 10 (21): 387-391 (1996).
Auexier and Greider, “Functional reconstitution of wild-type and mutantTetrahymenatelomerase,” (1994)Genes Develop., 8:563.
Avilion, A., “Characterization and expression of human telomerase,” Dissertation Abstracts International, 56 (11) 5930-B (1996).
Barinaga, M., “The Telomerase Picture Fills In,” Science 276:528-529 (1997).
Berger and Kimmel,Guide to Molecular Cloning Techniques, Meth. Enzymol., vol. 152, Academic Press, San Diego CA (1987).
Blessmann et al., “Addition of Telomere-Associated HeT DNA Sequences “Heals” Broken Chromosome Ends in Drosophila,” Cell 61:663 [1990].
Bitter et al., “Expression and secretion vectors for yeast,” Meth Enzymol., (1987) 153:516.
Blackburn and Chiou, “Non-nucleosomal packaging of a tandemly repeated DNA sequence at termini of extrachromosomal DNA coding for rRNA in Tetrahymena,” (1981)Proc. Natl. Acad. Sci.,78:2263.
Blackburn and Gall, “A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes inTetrahymena,” (1978)J. Mol. Biol.,120:33.
Blackburn, “Telomerases,” (1992)Ann. Rev. Biochem.,61:113.
Bodnar et al., “Extension of Life-Span by Introduction of Telomerase in Normal Human Cells,” (1998)Science, 279:349.
Bradford, “A Rapid and Sensitive method for Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding,” (1976)Anal. Biochem.,72:248.
Braunstein et al., “Transcriptional silencing in yeast is associated with reduced acetylation,” (1993)Genes Develop., 7:592.
Calvio et al., “Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry,” (1995)RNA, 1:724.
Caruthers et al., “New chemical methods for synthesizing polynucleotides,” (1980)Nucleic Acids Res. Symp. Ser.,215-223.
Chan and Tye, “Organization of DNA sequences and replication origins at yeat telomeres,” (1983)Cell, 33:563.
Colbere-Garapin et al., “A new dominat hybrid selective marker for higher eukaryotic cells,” (1981)J. Mol. Biol.,150:1.
Cole et al., “The EBV-hybridoma technique and its application to human lung cancer,” Monoclonal Antibodies and Cancer Therapy, Alan R. Liss Inc., New York NY 77-96 (1985).
Collins et al., “Purification of Tetrahymena telomerase and cloning of genes encoding the two peotein components of the enzyme,” (1995)Cell, 81:677.
Collins, K., “Structure and Function of Telomerase,” Curr. Op. Cell. Biol. 8:374-380 (1996).
Conrad et al., “RAP1 protein interacts with yeast telomers in vivo: Overproduction alters telomere structure and decreases chromosome stability,” (1990) Cell, 63:739.
Coombs,Dictionary of Biotechnology, Stockton Press, New York NY (1994).
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,” (1983)Proc. Natl. Acad. Sci.,80:2026.
Counter et al., “The catalytic subunit of yeast telomerase,” (1997)Proc. Natl. Acad. Sci.,94:9202.
Creighton, Proteins, Structures and Molecular Principles, WH Freeman and Co, New York NY [1983].
Dieffenbach and Dveksler,PCR Primer, a Laboratory Manual, Cold Spring Harbor Press, Plainview NY (1995).
Duplaa et al., “Quantitative analysis of polymerase chain reaction products using biotinylated dUTP incorporation,” (1993)Anal. Biochem., 212:229.
Fang et al., “Oxytricha telomere-binding protein: separable DNA-binding a
Andrews William H.
Cech Thomas R.
Chapman Karen B.
Harley Calvin B.
Lingner Joachim
Geron Corporation
The Regents of the University of Colorado
Townsend and Townsend / and Crew LLP
Ungar Susan
LandOfFree
Antibody to telomerase reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody to telomerase reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody to telomerase reverse transcriptase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840602